References
- Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401–5.
- Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel-like sequences associated with human hepatitis. Nat Med 1995;1:564–9.
- Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, et al. Genomic organization of GB viruses A and B: two members of the flaviviridae associated with GB agent hepatitis. J Virol 1995;69:5621–30.
- Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505–8.
- Zuckerman AJ. Alphabet of hepatitis viruses. Lancet 1996;347:558–9.
- Goudeau A, Maupas P, Dubois F. Hepatitis B infection in alcoholic liver disease and primary hepatocellular carcinoma in France. Prog Med Virol 1981;27:26–34.
- Nalpas B, Thiers V, Pol S, Driss F, Thépot V, Berthelot P, et al. Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 1992;14:381–4.
- Shiomi S, Kuroki T, Minamitani S, Ueda T, Nishiguchi S, Nakajima S, et al. Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol 1992;7:274–6.
- Kanel GC. Alcoholic liver disease. In: Kanel GC, Korula J, editors. Atlas of liver pathology. Philadelphia: WB Saunders; 1992. p. 53–65.
- Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M, Caballeria J, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996;24:1399–403.
- Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, et al. Detection of antibodies to a putative G virus envelope protein. Lancet 1997;349:318–20.
- Persico T, Thiers V, Tuveri R, Di Fine M, Semprini AE, Bréchot C. Detection of hepatitis G/GB-C viral RNA but not HCV RNA in the different semen fractions of infected patients [abstract]. J Hepatol 1996;25 Suppl 1:77.
- Alter M, Gallacher M, Morris TT, Moyer LA, Meeks EL, Krawczynski F, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997;336:741–6.
- Alter H, Nakatsuji Y, Melpoder J, Wages J, Wesley R, Shih JWK, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336:747–54.
- Bralet MP, Roudot-Thoraval F, Pawlotsky JM, Bastie A, Tran Van Nhieu J, Duval J, et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 1997;112:188–92.
- Kubo S, Nishiguchi S, Kuroki T, Hirohashi K, Tanaka H, Tsukamoto T, et al. Poor association of GBV-C viremia with hepatocellular carcinoma. J Hepatol 1997;27:91–95.
- Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131–2.
- Heringlake S, Osterkamp S, Trauwein C, Tillmann HL, Böker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996;348:1626–9.
- Laskus T, Wang LF, Radkowski M, Jang SJ, Vargas H, Dodson F, et al. Hepatitis G virus infection in american patients with cryptogenic cirrhoses: no evidence for liver replication [abstract]. Hepatology 1997;26:152A.